Enzo Biochem
Quarterly Financials
| Values in thousands | 2025-01-31 | 2024-10-31 | 2024-07-31 | 2024-04-30 |
|---|---|---|---|---|
Revenue | $7,334 | $6,213 | $7,526 | $8,022 |
Gross Profit | 3,785 | 2,532 | 3,220 | 3,733 |
EBITDA | -1,284 | -2,845 | -2,219 | -1,014 |
EBIT | -1,602 | -3,164 | -2,617 | -1,351 |
Net Income | -1,535 | -3,376 | -13,381 | -3,020 |
Net Change In Cash | 7,334 | 6,213 | 7,526 | 8,022 |
Free Cash Flow | -2,096 | -9,438 | -1,208 | -3,005 |
Cash | 40,297 | 47,735 | 52,371 | 62,156 |
Basic Shares | 52,297 | 52,244 | 52,244 | 51,214 |
Annual Financials
| Values in thousands | 2024-07-31 | 2023-07-31 | 2022-07-31 | 2021-07-31 |
|---|---|---|---|---|
Revenue | $31,907 | $31,061 | $107,071 | $117,731 |
Gross Profit | 14,632 | 11,566 | 41,967 | 53,577 |
EBITDA | -8,348 | -20,941 | -15,007 | 3,345 |
EBIT | -9,620 | -23,623 | -17,834 | 692 |
Net Income | -26,078 | 20,288 | -22,578 | 3,425 |
Net Change In Cash | 31,907 | 31,061 | 107,071 | 117,731 |
Cost of Revenue | 8,392 | |||
Free Cash Flow | -26,804 | -39,736 | -20,062 | -4,049 |
Cash | 52,371 | 82,373 | 21,603 | 13,524 |
Basic Shares | 50,902 | 49,160 | 48,594 | 48,325 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-01-31 | -$0.02 |
2024-10-31 | -$0.06 |
2024-07-31 | -$0.25 |
2024-04-30 | -$0.05 |
